The natural compound berberine, which is present in plants like goldenseal and barberry, has promise for the treatment of lung diseases.
The natural compound berberine, which is present in plants like goldenseal and barberry, has promise for the treatment of lung diseases.
According to a recent study, the natural compound berberine, which is present in plants like goldenseal and barberry, inhibits the growth of lung cancer cells in the lab. It also lessens inflammation of the airways and reduces the damage to healthy lung cells exposed to the toxins from cigarette smoke.
Around 1.8 million deaths from lung cancer are reported each year, making it the leading cause of cancer-related deaths worldwide. Chronic inflammation increases the risk of lung cancer and other disorders including chronic obstructive pulmonary disease (COPD) and asthma.
“Berberine has shown therapeutic benefits for diabetes and cardiovascular disease. We were keen to explore its potential in suppressing lung cancer and reducing inflammation,” says lead researcher Dr. Kamal Dua, a senior lecturer in Pharmacy at the University of Technology Sydney (UTS).
In a study recently published in the journal Pharmaceutics, berberine’s impact on non-small cell lung cancer has been evaluated. It demonstrates that berberine has significant anticancer activity, suppressing the growth of cancer cells in vitro.
By assessing the mRNA levels of tumor-associated genes and protein expression levels, the potential mechanism of action for anti-cancer efficacy was identified. It demonstrated that berberine regulates proteins involved in cancer cell migration and proliferation while upregulating genes known to decrease tumor growth.
The study is a follow-up to research led by Dr. Dua that was recently published in the journal Antioxidants and demonstrated that berberine may inhibit oxidative stress, reduce inflammation, and slow down cellular senescence caused by cigarette smoke extract in lab-grown human healthy lung cells.
Professors Phil Hansbro, Brian Oliver, Bikash Manandhar, and Keshav Raj Paudel were also members of the research team. International colleagues from Qassim University in Saudi Arabia and the International Medical University in Malaysia also contributed.
Dr. Dua’s focus is on exploring the curative potential of traditional medicinal plants and how their active compounds work at the cellular level. He has a multi-faceted research background with experience in drug delivery technology, biomedical sciences, immunology, and microbiology.
Berberine has long been used in traditional Chinese and Ayurvedic medicine, however, its therapeutic benefits have been limited by its lack of water solubility and absorption in the gut, as well as toxicity at higher doses.
To overcome these challenges Dr. Dua has developed the use of liquid crystalline nanoparticles, an advanced drug delivery system that encapsulates berberine in tiny soluble and biodegradable polymer balls to enhance safety and effectiveness.
Decades of research have shown that cigarette smoke is toxic to lung cells, causing inflammation of the airways and hastening diseases such as cancer, chronic obstructive pulmonary disease (COPD), and asthma.
The researchers found that berberine suppressed the generation of inflammatory chemicals, called reactive oxygen species, which cause damaging effects to cells. It also modulated genes involved in inflammation, oxidative stress, and reduced premature cell senescence.
Dr. Dua is now in discussion and working closely with Sydney-based companies to take this research to the next level and identify the best formulation and delivery system for these nanoparticles so that they can be translated to the bedside.
References: “Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine–Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro” by Abdullah M. Alnuqaydan, Abdulmajeed G. Almutary, Mohd Azam, Bikash Manandhar, Geena Hew Suet Yin, Lee Li Yen, Thiagarajan Madheswaran, Keshav Raj Paudel, Philip M. Hansbro, Dinesh Kumar Chellappan and Kamal Dua, 24 May 2022, Pharmaceutics.
DOI: 10.3390/pharmaceutics14061119
“Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 Cells” by Keshav Raj Paudel, Nisha Panth, Bikash Manandhar, Sachin Kumar Singh, Gaurav Gupta, Peter R. Wich, Srinivas Nammi, Ronan MacLoughlin, Jon Adams, Majid Ebrahimi Warkiani, Dinesh Kumar Chellappan, Brian G. Oliver, Philip M. Hansbro and Kamal Dua, 28 April 2022, Antioxidants.
DOI: 10.3390/antiox11050873
Original article by admin, if reproduced, please cite the source as: https://www.tcmha.com/tcmnews/traditional-chinese-medicine-shows-promise-in-treating-lung-cancer.html
相关推荐
-
Chinese support needed in Cambodia to boost Traditional Chinese Medicine
Chinese participants highlighted the importance of quality control in traditional medicine, which spans from the procurement of raw materials to the delivery of the final products.
-
Minister reveals plans to build center for traditional Chinese medicine in Belarus
The Center for Traditional Chinese Medicine (TCM) to be built in Belarus will follow the same philosophy as similar centers in China, Healthcare Minister Dmitry Pinevich told the Panorama program on the Belarus 1 TV channel, BelTA informs.
-
Study Finds Traditional Chinese Medicine Is As Effective as Drugs in Treating a Certain Type of Infection
A clinical trial demonstrates that Yupingfeng, a traditional Chinese medicine, is as effective as allopathic drugs at treating children with recurrent respiratory tract infections.
-
Pakistan says trial of Chinese traditional medicine for COVID-19 successful
KARACHI, Pakistan, Jan 17 (Reuters) – Pakistani health authorities on Monday announced the completion of a successful clinical trial of Chinese traditional herbal medicine for treating COVID-19, as the South Asian nation enters a fifth wave of the pandemic driven by the Omicron variant. The Chinese medicine, Jinhua Qinggan Granules (JHQG) manufactured by Juxiechang (Beijing) pharmaceutical Co Ltd, is already being used in treatment of COVID-19 patients in China. “Since it was tried on patients with different variants of COVID-19, we expect it to be effective on Omicron as on…
-
Fever reduction rate of more than 95% in 3 days! Eight Questions and Eight Answers” of Shanghai Traditional Chinese Medicine for COVID-19
Traditional Chinese medicine has always played an important role in the treatment of COVID-19. On March 31, a medical team from Longhua Hospital of Shanghai University of Traditional Chinese Medicine assembled and 201 people went to the temporary centralized isolation and treatment site of the New International Expo Center to carry out their work. The reporter invited Zhang Wei, a member of the Shanghai Expert Group on Prevention and Control of COVID-19 in Chinese Medicine and Director of the Department of Respiratory Medicine of Shuguang Hospital affiliated to Shanghai University…
-
Chinese traditional medicine makes its way into Kenyan market
FOHOW’s entry into the Kenyan market aligns with China’s Belt and Road Initiative (BRI) objectives, focusing on providing quality healthcare services and employment opportunities for local communities, Liu disclosed.
-
Economic Watch: Traditional Chinese medicine bolsters rural development in Yunnan
KUNMING, March 22 (Xinhua) — From laboratories to farmland, Yang Shaobing has helped those in remote areas in southwest China find a new cash cow by planting traditional Chinese medicinal herbs. Yang, a 37-year-old researcher with the Yunnan Provincial Academy of Agricultural Sciences, arrived in the Dulongjiang Township in Nujiang Lisu Autonomous Prefecture, Yunnan Province, in 2016 to aid locals in poverty alleviation. Dulongjiang is home to the Dulong people, an ethnic minority group that long endured poverty and poor access to the outside world. In Dulongjiang, Yang guided the…
-
Traditional Chinese Medicines ignore science, pose safety concerns, says report
The presence of toxins in Traditional Chinese Medicines (TCM), their questionable clinical trials and lack of scientific evidence about their efficacy are raising many eyebrows. The detailed results of the trials of TCM are also not being published in public and the presence of toxins is not indicated on the packaging of TCM products due to lack of guidelines and required regulations, according to Inside Over. Arthur Grollman, a cancer researcher at Stony Brook University in New York, has published work showing how Aristolochic acid, an ingredient in many TCM…
-
The 1st Int’l Forum on Digital Credit and Technology to enhance International Quality practice of TCM
The 1st Int’l Forum on Digital Credit and Technology to enhance International Quality practice of TCM & the 2021 Annual Meeting of the Kampo Pharmaceutical Research Center of the China-Japan Medical Science and Technology Exchange Association was held simultaneously in multiple venues via video link on Dec. 28. Representatives from governments, industry, research, academy and international organizations of China’s mainland, Macao, Japan, Singapore, Malaysia and other countries and regions, focused on the discussion of guiding the in-depth integration of digital technology with the traditional Chinese medicine (TCM) industry, advancing digitalization…
-
Why does even the US Air Force trust traditional Chinese medicine?
According to Nouvelles d’Europe, in 2018, the World Health Organization included TCM into its globally influential medical program for the first time. This shows that TCM is really an effective medical treatment that can fill in the blanks of Western medicine.
